[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.82.105. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
December 23, 1974

Management of Hyperlipidemias

Author Affiliations

Ms. Murphy is Junior Scientist, AMA Department of Drugs. This communication was prepared with the assistance of consultants.

JAMA. 1974;230(12):1683-1691. doi:10.1001/jama.1974.03240120051025
Abstract

The treatment of hyperlipidemia is desirable, especially in patients with a family history of premature ischemic heart disease, but only after the specific type of hyperlipoproteinemia has been determined. Secondary causes of hyperlipoproteinemia should be sought and eliminated. Dietary regulation remains the primary therapeutic approach; adjunctive chemotherapy is indicated only when dietary control is unsuccessful. Several drugs will reduce lipid levels, but the long-term effects of these drugs are unknown.

(JAMA 230:1683-1691, 1974)

×